- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Targeting Soluble Clever-1 for Autoimmune Diseases
- Shareholders’ Nomination Board
- Faron’s Capital Markets Day 2024
- Faron announces Capital Markets Day
- Grant of options
- Faron 2024 Half-Year Financial Results
- FDA Grants Fast Track Designation for Bexmarilimab
- Notice of Half-Year Financial Results
- Traumakine Research Collaboration and DoD Grant
- Appointment of Chief Financial Officer
More ▼
Key statistics
On Friday, Faron Pharmaceuticals Oy (FARN:LSE) closed at 142.50, 67.65% above the 52 week low of 85.00 set on Jun 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 142.50 |
---|---|
High | 156.00 |
Low | 142.50 |
Bid | 137.00 |
Offer | 167.00 |
Previous close | 142.50 |
Average volume | 7.54k |
---|---|
Shares outstanding | 104.62m |
Free float | 71.34m |
P/E (TTM) | -- |
Market cap | 148.85m GBP |
EPS (TTM) | -0.3161 GBP |
Data delayed at least 20 minutes, as of Nov 22 2024 14:00 GMT.
More ▼